Sorafenib induced acral pigmentation: A new entity

Sorafenib induced acral pigmentation: A new entity

Sorafenib is a multikinase inhibitor commonly used for the treatment of advanced renal cell and hepatocellular carcinoma. The commonly reported dermatological adverse effects of Sorafenib include hand-foot syndrome (HFS), alopecia, pruritus, facial and scalp erythema, splinter hemorrhages, keratoaca...

Full description

Bibliographic Details
Main Authors: Mrinal Gupta, Heena Gupta, Anish Gupta
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2015-04-01
Series:Avicenna Journal of Medicine
Subjects:
acral pigmentation
hand foot syndrome
sorafenib
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/2231-0770.154199

Similar Items

Similar Items